Lin Sang

Beijing Fengtai Hospital

Papers

1

Total Citations

21

H-Index

1

About

Lin Sang is a leading researcher in the field of epilepsy surgery, with a primary focus on improving the precision and safety of stereoelectroencephalography (SEEG) for drug-resistant epilepsy. Her most cited work, a 2022 study comparing robot-guided and stereotactic frame-based SEEG electrode implantation, has garnered 21 citations and represents a pivotal contribution to the optimization of minimally invasive epilepsy monitoring techniques. Sang’s research directly addresses the critical challenge of accurately localizing epileptogenic zones while minimizing patient risk, demonstrating that robot-assisted approaches can enhance implantation accuracy and reduce procedural complications. Her comparative analysis has provided essential evidence for the growing adoption of robotic systems in epilepsy surgery centers worldwide. Beyond this landmark study, Sang continues to advance the field through investigations into surgical outcomes and technological innovations in SEEG. Her work is highly regarded for its practical clinical implications, helping to refine treatment protocols for patients with refractory epilepsy. With a focus on translating engineering advancements into tangible patient benefits, Lin Sang’s research stands at the intersection of neurosurgery, robotics, and clinical neurology, making her a key figure in the evolution of modern epilepsy care.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
A comparison between robot-guided and stereotactic frame-based stereoelectroencephalography (SEEG) electrode implantation for drug-resistant epilepsy
21 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Beijing Fengtai Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago